Aura Biosciences (AURA) Current Assets (2020 - 2026)

Aura Biosciences has reported Current Assets for 7 years, with the latest figure at $118.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 11.9% year-over-year to $118.5 million; the trailing twelve-month figure through Mar 2026 stood at $118.5 million (down 11.9% YoY), and the FY2025 full-year result was $149.7 million, down 6.78% from the prior year.
• Current Assets for Q1 2026 stood at $118.5 million, down from $149.7 million in the prior quarter.
• The five-year high for Current Assets was $231.8 million in Q4 2023, with the low at $115.9 million in Q3 2022.
• Historically, Current Assets has averaged $165.9 million across 5 years, with a median of $166.2 million in 2023.
• Annual changes were most pronounced in 2022 — Current Assets soared 38.88% — and 2025, when it plunged 36.62%.
• Aura Biosciences' Current Assets stood at $196.7 million in 2022, then climbed by 17.84% to $231.8 million in 2023, then tumbled by 30.7% to $160.6 million in 2024, then declined by 6.78% to $149.7 million in 2025, then retreated by 20.86% to $118.5 million in 2026.
• The last three Current Assets figures came in at $118.5 million (Q1 2026), $149.7 million (Q4 2025), and $170.1 million (Q3 2025), per Business Quant data.